Legal30 Jul 2026, 09:10 pm
AstraZeneca Pharma India Receives ₹148.6 Cr Demand Notice from NPPA
AI Summary
AstraZeneca Pharma India Ltd has received a demand notice from the National Pharmaceutical Pricing Authority (NPPA) for alleged overcharging under the Drugs (Prices Control) Order, 2013. The notice, dated July 29, 2026, pertains to Symbicort Turbuhaler and demands ₹1,48,65,83,590, inclusive of interest calculated up to August 20, 2026. This amount is payable within 30 days. The company is currently evaluating the notice and considering appropriate legal actions. The alleged overcharging relates to the period from May 2016 to November 2025.
Key Highlights
- NPPA issued a demand notice for alleged overcharging.
- Demand amounts to ₹1,48,65,83,590 including interest.
- The notice concerns Symbicort Turbuhaler for the period May 2016-Nov 2025.
- Company is evaluating legal options.
- Payment is due within 30 days of receipt.
Price Impact
More from ASTRAZEN